EvoPlexus Medics ApS: Financial statements 2023
CVR: 40782001
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
EvoPlexus Medics ApS (CVR 40782001) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -65,066 and a net result of DKK -65,090 compared with DKK -77,761 the year before. Equity in the 2023 report amounted to DKK -160,160.
- Gross Profit
- DKK -65,066
- Profit/Loss
- DKK -65,090
- Equity
- DKK -160,160
- Total Assets
- DKK 6,922
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -65 t. | -65 t. | -160 t. | - |
| 2022 | - | -78 t. | -78 t. | -95 t. | - |
| 2021 | - | -47 t. | -47 t. | -17 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
EvoPlexus Medics ApS has published its annual report for 2022. Gross profit came to DKK -77,745, and the net result was DKK -77,761.
About EvoPlexus Medics ApS
EvoPlexus Medics ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2019. The company is registered under the industry Computerprogrammering. The management consists of Serkawt Khola. The company is owned by EvoPlexus Holding ApS. According to the 2021 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -50,496 and a net result of DKK -50,498 compared with DKK -38,945 the year before. Equity in the 2025 report amounted to DKK -249,603.